Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

GP73 is a glucogenic hormone regulating SARS-CoV-2-induced hyperglycemia

Luming Wan, Huan Yang, Huilong Li, Jing Gong, Yongqiang Deng, Yuehua Ke, Xiaopan Yang, Haotian Lin, Yanhong Zhang, Changjun Wang, Dongyu Li, Huapeng Wang, Yumeng Peng, Qiulin Yan, Linfei Huang, Xiaolin Wang, Qi Gao, Changqing Lin, Fei Zheng, Lei Xu, Jialong Liu, Xuemiao Zhang, Xiaoli Yang, Chengfeng Qin, Zhiwei Sun, Feixiang Wu, Congwen Wei, Hui Zhong
doi: https://doi.org/10.1101/2021.04.30.21256060
Luming Wan
1Beijing Institute of Biotechnology, Beijing, 100850, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Huan Yang
2Guangxi liver cancer Diagnosis and Treatment Engineering and Technology research center, Nanning, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Huilong Li
2Guangxi liver cancer Diagnosis and Treatment Engineering and Technology research center, Nanning, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jing Gong
1Beijing Institute of Biotechnology, Beijing, 100850, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yongqiang Deng
3Beijing Institute of Microbiology and Epidemiology, Beijing, 100850, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuehua Ke
4Center for Disease Control and Prevention of PLA, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaopan Yang
1Beijing Institute of Biotechnology, Beijing, 100850, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Haotian Lin
1Beijing Institute of Biotechnology, Beijing, 100850, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yanhong Zhang
1Beijing Institute of Biotechnology, Beijing, 100850, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Changjun Wang
4Center for Disease Control and Prevention of PLA, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dongyu Li
1Beijing Institute of Biotechnology, Beijing, 100850, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Huapeng Wang
1Beijing Institute of Biotechnology, Beijing, 100850, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yumeng Peng
1Beijing Institute of Biotechnology, Beijing, 100850, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qiulin Yan
1Beijing Institute of Biotechnology, Beijing, 100850, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Linfei Huang
1Beijing Institute of Biotechnology, Beijing, 100850, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaolin Wang
1Beijing Institute of Biotechnology, Beijing, 100850, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qi Gao
5Hotgen Biotech Co., Ltd. Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Changqing Lin
5Hotgen Biotech Co., Ltd. Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fei Zheng
5Hotgen Biotech Co., Ltd. Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lei Xu
5Hotgen Biotech Co., Ltd. Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jialong Liu
6Department of Clinical Laboratory, the Third Medical Centre, Chinese PLA General Hospital, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xuemiao Zhang
6Department of Clinical Laboratory, the Third Medical Centre, Chinese PLA General Hospital, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaoli Yang
6Department of Clinical Laboratory, the Third Medical Centre, Chinese PLA General Hospital, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chengfeng Qin
3Beijing Institute of Microbiology and Epidemiology, Beijing, 100850, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhiwei Sun
5Hotgen Biotech Co., Ltd. Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Feixiang Wu
2Guangxi liver cancer Diagnosis and Treatment Engineering and Technology research center, Nanning, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Congwen Wei
1Beijing Institute of Biotechnology, Beijing, 100850, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hui Zhong
1Beijing Institute of Biotechnology, Beijing, 100850, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: towall@yahoo.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Summary

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection induces new-onset diabetes and severe metabolic complications of pre-existing diabetes. The pathogenic mechanism underlying this is incompletely understood. Here, we provided evidence linking circulating GP73 with the exaggerated gluconeogenesis triggered by SARS-CoV-2 infection. We found that SARS-CoV-2 infection or glucotoxic condition increased the cellular secretion of GP73. Secreted GP73 trafficked to the liver and kidney to stimulate gluconeogenesis through cAMP/PKA pathway. By using global phosphoproteomics, we found a drastic remodeling of PKA kinase hub exerted by GP73. Notably, COVID-19 patients showed pathologically elevated plasma GP73, and neutralization of the secreted GP73 inhibited enhanced PKA signaling and glucose production associated with SARS-CoV-2 infection. GP73 blockade also reduced gluconeogenesis and lowered hyperglycemia in type 2 (T2D) diabetic mice. Therefore, our findings provide novel insight into the roles of GP73 as a key glucogenic hormone and mechanistic clues underlying the development of SARS-CoV-induced glucose abnormalities.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

We thank the National Key Research and Development Programme of China (grant no. 2018YFA0900800) and National Natural Science Foundation of China (grant nos. 31872715 32070755 81773205 and 82070595) for their support. Graphical abstract was created and exported with BioRender.com under a paid subscription.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Ethics Committee of Huoshenshan Hospital approved the study (HSSLL036). Given the urgency of the COVID-19 pandemic, the need for informed consent forms was waived by the ethics boards of the hospitals. The Committee for Ethics in Human Studies from the Third Medical Center of the Chinese PLA General Hospital approved this study (KY2021-009).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵8 These authors jointly supervised the work: Xiaoli Yang, Chengfeng Qin, Zhiwei Sun, Feixiang Wu, Congwen Wei, and Hui Zhong

Data Availability

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact Hui Zhong (towall{at}yahoo.com).

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted May 03, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
GP73 is a glucogenic hormone regulating SARS-CoV-2-induced hyperglycemia
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
GP73 is a glucogenic hormone regulating SARS-CoV-2-induced hyperglycemia
Luming Wan, Huan Yang, Huilong Li, Jing Gong, Yongqiang Deng, Yuehua Ke, Xiaopan Yang, Haotian Lin, Yanhong Zhang, Changjun Wang, Dongyu Li, Huapeng Wang, Yumeng Peng, Qiulin Yan, Linfei Huang, Xiaolin Wang, Qi Gao, Changqing Lin, Fei Zheng, Lei Xu, Jialong Liu, Xuemiao Zhang, Xiaoli Yang, Chengfeng Qin, Zhiwei Sun, Feixiang Wu, Congwen Wei, Hui Zhong
medRxiv 2021.04.30.21256060; doi: https://doi.org/10.1101/2021.04.30.21256060
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
GP73 is a glucogenic hormone regulating SARS-CoV-2-induced hyperglycemia
Luming Wan, Huan Yang, Huilong Li, Jing Gong, Yongqiang Deng, Yuehua Ke, Xiaopan Yang, Haotian Lin, Yanhong Zhang, Changjun Wang, Dongyu Li, Huapeng Wang, Yumeng Peng, Qiulin Yan, Linfei Huang, Xiaolin Wang, Qi Gao, Changqing Lin, Fei Zheng, Lei Xu, Jialong Liu, Xuemiao Zhang, Xiaoli Yang, Chengfeng Qin, Zhiwei Sun, Feixiang Wu, Congwen Wei, Hui Zhong
medRxiv 2021.04.30.21256060; doi: https://doi.org/10.1101/2021.04.30.21256060

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Endocrinology (including Diabetes Mellitus and Metabolic Disease)
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (579)
  • Anesthesia (140)
  • Cardiovascular Medicine (1947)
  • Dentistry and Oral Medicine (252)
  • Dermatology (185)
  • Emergency Medicine (333)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (700)
  • Epidemiology (11108)
  • Forensic Medicine (8)
  • Gastroenterology (626)
  • Genetic and Genomic Medicine (3182)
  • Geriatric Medicine (309)
  • Health Economics (563)
  • Health Informatics (2043)
  • Health Policy (863)
  • Health Systems and Quality Improvement (782)
  • Hematology (310)
  • HIV/AIDS (682)
  • Infectious Diseases (except HIV/AIDS) (12729)
  • Intensive Care and Critical Care Medicine (707)
  • Medical Education (317)
  • Medical Ethics (92)
  • Nephrology (336)
  • Neurology (2993)
  • Nursing (164)
  • Nutrition (465)
  • Obstetrics and Gynecology (589)
  • Occupational and Environmental Health (614)
  • Oncology (1556)
  • Ophthalmology (478)
  • Orthopedics (185)
  • Otolaryngology (266)
  • Pain Medicine (202)
  • Palliative Medicine (57)
  • Pathology (403)
  • Pediatrics (914)
  • Pharmacology and Therapeutics (382)
  • Primary Care Research (355)
  • Psychiatry and Clinical Psychology (2789)
  • Public and Global Health (5597)
  • Radiology and Imaging (1095)
  • Rehabilitation Medicine and Physical Therapy (635)
  • Respiratory Medicine (761)
  • Rheumatology (339)
  • Sexual and Reproductive Health (311)
  • Sports Medicine (289)
  • Surgery (343)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (133)